Pfizer, GSK create consumer health powerhouse

Published December 19, 2018 12:35pm ET



Pharmaceutical giants Pfizer and GlaxoSmithKline are combining their over-the-counter drugs and healthcare products to create a new joint venture.

The drugs include well-known brands, such as the painkillers Advil and Excedrin, Sensodyne toothpaste, Tums, and the vitamin brands Centrum and Caltrate. The companies plan to finalize the deal in the second half of 2019, and will split off the consumer part of the business after three years, at which point it will become the largest seller of over-the-counter products in the world.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.